By integrating transcriptomic data, compound–protein interactions, structural similarity, and enrichment analysis, we identified overlapping molecular features and biological processes that suggest possible mechanistic links among EVOO, NRF2 modulation, and AD-related pathways. Here, NFE2L2 is linked to Alzheimer disease.